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In patients with cystic ﬁbrosis (CF) mutations in the epithelial chloride channel
CFTR lead to increased ceramide and apoptosis. Because apoptotic bodies are
recognized as autoantigens by the adaptive immune system we hypothesized that
autoantibodies are present in blood of CF patients. Here we show that the majority
of CF patients are persistently positive for autoantibodies to typical antinuclear
antigens (ANA), also present in patients with systemic lupus erythematosus (SLE).
Because invariant Natural Killer T (iNKT) cells may limit autoreactive B cells,
we hypothesized that CF patients, similar to SLE patients, express low numbers of
iNKT cells. Indeed, CF patients revealed signiﬁcantly lower numbers of iNKT cells
compared to healthy individuals. In contrast, CF KO mice revealed highly elevated
iNKT cells in several organs and normal serum autoantibody levels, while gut
corrected CF MHH mice, revealing less elevated iNKT cells, showed slightly
increased autoantibody levels. iNKT cell numbers were also increased in brain
tissues of CF MHH mice, excluding that accumulation of iNKT cell in CF mice is
a consequence of microbial infection. iNKT cells recruited macrophages into lung
tissues of CF MHH mice, probably eliminating apoptotic bodies. Genetic deletion
of iNKT cells in CF MHH mice (CF MHH/Ja18) resulted in signiﬁcantly elevated
autoreactive B cell in spleen and lung and circulating autoantibody levels. This
work established a novel link between CF and autoimmunity and demonstrates that
iNKT cells in CF patients are not sufﬁcient to control autoantibody production
against apoptotic cell antigens in contrast to the CF KO mouse strain.
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Objectives: Despite ample evidence of dysregulated innate immunity in cystic
ﬁbrosis lung disease a role for adaptive immune impairment has been sparsely
studied. The objective of this work was to use an ex vivo primary human model
to investigate the interaction of airway epithelial cells with dendritic cells. We
hypothesised that cystic ﬁbrosis airway epithelial cells skew adaptive immunity to
favour chronic infection and lung damage in people with cystic ﬁbrosis.
Methods: We isolated cystic ﬁbrosis primary human bronchial epithelial cells and
assessed their modulation of monocyte-derived dendritic cells (moDC). Monocytes
were cultured with conditioned medium from cystic ﬁbrosis primary bronchial ep-
ithelial cells (n = 6 individual patients) during moDC maturation with interleukin-4
and granulocyte macrophage-colony stimulating factor. Expression of typical den-
dritic cell and macrophage markers was measured by ﬂow cytometry to assess
resulting phenotype. Compared to control moDC, cystic ﬁbrosis epithelial cell
conditioned moDC were tolerogenic and macrophage-like (↓CD1a, ↓CD86, ↑CD14
and ↑IL-10), inducing low T cell proliferation and interferon-g production in an
allogeneic mixed lymphocyte reaction.
Conclusions: We conclude that cystic ﬁbrosis airway epithelial cells secrete factors
that contribute to immune tolerance and may be permissive of chronic infection.
This may represent an important novel mechanism that contributes to the patho-
genesis of cystic ﬁbrosis lung disease.
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Fungal colonization with Aspergillus fumigatus (A. fumigatus) in cystic ﬁbrosis (CF)
is increasingly recognized. While allergic bronchopulmonary aspergillosis (ABPA)
leads to a deterioration of pulmonary function, the effect of A. fumigatus coloniza-
tion in the absence of ABPA remains unexplored. To address this we examined a
cohort of CF individuals with A. fumigatus who were ABPA-negative to identify
the effects of itraconazole therapy on Aspergillus-induced lung inﬂammation.
We demonstrate using in vitro cell models that A. fumigatus downregulates the
nuclear vitamin D receptor (VDR) in airway epithelial cells and that the secondary
metabolite gliotoxin (Gt) is the main causative agent, resulting in a heightened Th2
response and increased interleukin (IL)-5 and IL-13 production.
In vivo, A. fumigatus positivity correlated with increased Gt in CF bronchoalveolar
lavage ﬂuid (BALF), mosaic pattern on high resolution computed tomography
(HRCT) and increased BALF levels of IL-5 and IL-13. Following airway eradication
of A. fumigatus with itraconazole, we observed decreased IL-5 and IL-13 in BALF,
improved respiratory symptoms and reduced infective exacerbations that correlated
with sustained pulmonary function.
This study provides rationale for the therapeutic effect of itraconazole and ad-
ditionally highlights the therapeutic potential of vitamin D supplementation in
preventing ABPA are only feasible with concurrent elimination of A. fumigatus with
itraconazole to permit VDR expression and its positive functional consequences.
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Cystic ﬁbrosis (CF) is characterised by neutrophil-dominated airway inﬂammation,
in part attributable to the potent chemotactic agent leukotriene B4. (LTB4). The aim
of this study was to investigate the ability of exogenous alpha-1 antitrypsin (AAT) to
inhibit LTB4 signaling. The biological consequence of the described AAT induced
inhibition was investigated at the level of neutrophil (PMN) released proteolytic
enzymes including azurocidin, a potent activator of human monocytic cells.
PMNs isolated from healthy control volunteers (n = 4) were stimulated with LTB4
(100 nM/ 2×107) in the presence and absence of AAT (27.5mM) for increasing
increments of time (0, 5, 10 and 20 min). The level of degranulated proteins
in surrounding supernatants was determined by western blot analysis. Proteins
investigated included myeloperoxidase, hCAP-18 and matrix metalloprotease-9 as
markers for primary, secondary and tertiary granule release respectively. Levels of
azurocidin released from primary granules and secretory vesicles was electrophoret-
ically examined.
In vitro data has shown that levels of degranulated MPO, hCAP-18 and MMP-9
were signiﬁcantly decreased in the presence of AAT (P< 0.05). Densitometry
of immuno-bands revealed that PMNs release azurocidin in response to LTB4,
an effect reversed by inclusion of AAT (P< 0.05). The mechanism of inhibition
involved direct binding of AAT to LTB4 as reduced vibrational ﬁne structure of the
LTB4/AAT UV absorbance spectrum indicated complexation of the two molecules
in solution.
The results of this study indicate that AAT can inhibit LTB4 signaling and further
justiﬁes the use of aerosolised AAT as an effective treatment for CF.
